Clinical Trial Update: The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study [Phase 3]

View source ↗

Summary

A Phase 3 trial (AURORA) investigated rosuvastatin's effect on aortic stiffness in hemodialysis patients. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• CRESTOR (Rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED